Becton Dickinson & Co Est. EPS Q / Q
Mi az Becton Dickinson & Co Est. EPS Q / Q?
A Est. EPS Q / Q az Becton Dickinson & Co. - 27.44%
Mi a Est. EPS Q / Q meghatározása?
A várható EPS negyedévenkénti növekedési üteme évről évre meghaladja a vállalat EPS-jének becsült növekedését a következő negyedévben az előző negyedévhez képest.
The prospective EPS growth rate is a predicted estimate of the earnings per share growth rate towards the current quarter and expressed as a percentage compared to the respective past quarter. The estimated earnings per share growth rate is an important factor for judging a company's value. Comparing EPS history with stock price history helps determine the most likely future direction of the stock price.
Earnings per share is the monetary value of earnings per outstanding share of common stock for a company. The EPS is usually calculated as profit without preferred dividends divided by weighted average of common stock shares over the past twelve months.
Est. EPS Q / Q a Health Care szektor a NYSE-on cégekben a Becton Dickinson & Co -hoz képest
Mit csinál Becton Dickinson & Co?
Becton, Dickinson and Company is a global medical technology company. The Company is engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, and others.
est. eps q / q -hoz hasonló cégek Becton Dickinson & Co
- Douglas Emmett Inc nak Est. EPS Q / Q 27.27% van
- Johnson Controls International plc nak Est. EPS Q / Q 27.27% van
- FS KKR Capital II nak Est. EPS Q / Q 27.27% van
- Silicon Laboratories Inc nak Est. EPS Q / Q 27.27% van
- Lululemon Athletica inc nak Est. EPS Q / Q 27.30% van
- AU Small Finance Bank nak Est. EPS Q / Q 27.41% van
- Becton Dickinson & Co nak Est. EPS Q / Q 27.44% van
- Rockwell Automation Inc nak Est. EPS Q / Q 27.47% van
- First Bank (NJ) nak Est. EPS Q / Q 27.50% van
- Salarius Pharmaceuticals nak Est. EPS Q / Q 27.50% van
- High Liner Foods nak Est. EPS Q / Q 27.50% van
- Nuvasive Inc nak Est. EPS Q / Q 27.50% van
- Advanced Enzyme Technologies nak Est. EPS Q / Q 27.55% van